What Is Guardian Pharmacy Services, Inc (GRDN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Guardian Pharmacy Services, Inc's intrinsic value is estimated at $15.17, suggesting the stock is overvalued at its current price of $39.67. With 12 out of 13 models flagging downside (-61.7% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $38.16 (-3.8%), versus Dynamic NAV at $1.50 (-96.2%). This +92.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About GRDN?
13 of 13 models are currently active for GRDN. All 13 active models suggest the stock trades above fair value. The Bayesian DCF estimates GRDN's intrinsic value at $10.56, implying -73.4% downside from the current price. See which stocks rank higher →
How Does GRDN Rank in Retail-Drug Stores and Proprietary Stores?
Among 5 Retail-Drug Stores and Proprietary Stores stocks, GRDN ranks #3 by Quality of Company score. CirclFi's QOC score of 7.2/10 evaluates 32 fundamental signals. A score of 7.2 indicates above-average quality.
Within the Retail-Drug Stores and Proprietary Stores space, Guardian Pharmacy Services, Inc competes in an environment where patent cliff exposure often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is GRDN a Value Trap?
The Value Trap algorithm is not active for GRDN. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Guardian Pharmacy Services, Inc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Guardian Pharmacy Services, Inc is rated at 7.2/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.
The gap between the most bullish and bearish model spans +92.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GRDN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GRDN's 13 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad